Alcohol Use Disorder (AUD)
Conditions
Brief summary
Excessive alcohol consumption is common in patients admitted to the intensive care unit (ICU). Among patients who survive an ICU admission, excessive alcohol consumption is associated with a higher risk of being admitted the hospital. In this study, the Investigators will compare an intervention designed to address excessive drinking in ICU survivors to usual care. This intervention combines motivational interviewing (MI) and shared decision making (SDM). MI and SDM share several core components including the development of a therapeutic alliance and promotion of autonomy. MI can be employed in the context of motivating a patient to change their drinking. Once this decision has been made, SDM can be employed to help a patient decide amongst multiple reasonable treatment options. The Investigators long-term goal is to test whether MI-SDM is better than usual care and whether multiple sessions of MI-SDM are better than a single session. This pilot clinical trial will demonstrate the feasibility of conducting a larger efficacy study to test these hypotheses.
Interventions
BEHAVIORALRecovery Navigator on an as needed basis up to 6 months
This group will undergo contact with Recovery Navigator on an as needed basis up to 6 months and then have a 3 month and 6 month follow-up visit.
BEHAVIORALRecovery Navigator prior to hospital discharge
This group will undergo one interaction with Recovery Navigator prior to hospital discharge and then have a 3 month and 6 month follow-up visit.
OTHERNo interaction with Recovery Navigator
This group will not have any interaction with Recovery Navigator. They will have a 3 month and 6 month follow-up visit.
Sponsors
University of Colorado, Denver
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Admission to the intensive care unit; 2. Age 18 years or older; 3. Resolution of critical illness, defined as the intention of the treating team to discharge the patient or downgrade their admission level from the ICU to a progressive care unit or the floor; 4. Resolution of delirium, defined by: * a Riker Agitation Sedation Scale score of 0, * a negative CAM ICU, and * confirmation from the treating team (nurse, physicians) that the patient is not delirious. 5. AUDIT-C score of 3 or greater for women and 4 or greater for men.
Exclusion criteria
1. Prisoner; 2. Pregnant; 3. Unable to speak or write in English; 4. Unable to provide informed consent; 5. Unable to provide a home or cell phone number plus at least one additional way to be contacted (mail, email, friend or family); 6. Expected survival less than 6 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Client Satisfaction and Acceptability of study | 6 months | Client satisfaction questionnaire (CSQ-8), with revisions to make it specific to the objectives of this study. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Subject willingness to be randomized | 6 months | The number of patients who refuse study participation due to refusal to undergo randomization. This will be collected to inform the feasibility and design of a larger effectiveness study. |
| Subject Dropout Rates | 3 and 6 months | The percentage of subjects who do not show up for study visits calculated for each arm of the study. |
| Subjects with at least one visit after discharge | 6 months | The percentage of subjects with at least one visit after discharge with the navigator. |
| Time per subject visit | 6 months | The amount of time per subject visit to determine feasibility of the intervention for a larger study. |
| Number of visits | 6 months. | the Number of visits total to help determine feasibility of the intervention for a larger study. |
| Initiation of treatment within 14 days. | 14 days | Initiation of treatment by attendance at one treatment session within 14 days as efficacy measure for larger trial. |
| Initiation of alcohol/drug treatment within 6 months | 6 months | Initiation of treatment by attendance at one treatment session within 6 months as efficacy measure for larger trial |
| Engagement in alcohol/drug treatment | 3 and 6 months | 2 or more inpatient admissions, outpatient visits, intensive outpatient encounters or partial hospitalizations as efficacy measure for larger trial |
| Completion of alcohol/drug treatment | 3 and 6 months | Completion of alcohol treatment program as efficacy measure for larger trial |
| Subject Recruitment Rate | 6 months | The following will be collected to determine the feasibility and design of a larger effectiveness study: recruitment rates calculated as the number of patients recruited per month per hospital. |
| Receipt of treatment for drug problems | 3 and 6 months | Receipt of treatment for drug problems as efficacy measure for larger trial. |
| Receipt of psychiatric treatment. | 3 and 6 months | Receipt of psychiatric treatment as efficacy measure for larger trial. |
| Number of days abstained from alcohol consumption | 30 days | Percentage of days abstinent from alcohol consumption in 30 day timeframe |
| Number of days with reported heavy alcohol consumption | 30 days | Percentage of days with reported heavy alcohol consumption in 30 day timeframe |
| Phosphatidylethanol (PEth) level at 6 months | 6 months | Phosphatidylethanol (PEth) level at 6 months compared against subject's self-reported alcohol consumption and measured by United States Drug Testing laboratory |
| Alcohol related problems measured by SIP-2R | 3 and 6 months | alcohol related problems assessed by administering the Short Inventory of Problems 2, revised (SIP-2R). |
| HADS anxiety assessment | 3 and 6 months | Anxiety assessed with 14 item Hospital Anxiety and Depression Scale (HADS). |
| HADS depression assessment | 3 and 6 months | Depression assessed with 14 item Hospital Anxiety and Depression Scale (HADS). |
| Post Traumatic Stress Disorder (PTSD) symptoms | 3 and 6 months. | PTSD symptoms assessed using the Impact of Events Scale, revised. |
| Hospital re admissions and emergency department visits | 3 and 6 months | Number of hospital readmission and emergency department visits as efficacy measure for larger trial |
Countries
United States
Outcome results
None listed